Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.

Thänert R, Reske KA, Hink T, Wallace MA, Wang B, Schwartz DJ, Seiler S, Cass C, Burnham CA, Dubberke ER, Kwon JH, Dantas G.

MBio. 2019 Aug 27;10(4). pii: e01977-19. doi: 10.1128/mBio.01977-19.

2.

Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.

Robinson JI, Weir WH, Crowley JR, Hink T, Reske KA, Kwon JH, Burnham CD, Dubberke ER, Mucha PJ, Henderson JP.

J Clin Invest. 2019 Aug 12;130:3792-3806. doi: 10.1172/JCI126905. eCollection 2019 Aug 12.

3.

Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.

Bulow C, Langdon A, Hink T, Wallace M, Reske KA, Patel S, Sun X, Seiler S, Jones S, Kwon JH, Burnham CA, Dantas G, Dubberke ER.

mSphere. 2018 Nov 21;3(6). pii: e00588-18. doi: 10.1128/mSphereDirect.00588-18.

4.

Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.

Dubberke ER, Reske KA, Hink T, Kwon JH, Cass C, Bongu J, Burnham CD, Henderson JP.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1330-1333. doi: 10.1017/ice.2018.225. Epub 2018 Sep 18.

PMID:
30226126
5.

Frequency of Instrument, Environment, and Laboratory Technologist Contamination during Routine Diagnostic Testing of Infectious Specimens.

Yarbrough ML, Kwon JH, Wallace MA, Hink T, Shupe A, Fraser VJ, Dubberke ER, Burnham CA.

J Clin Microbiol. 2018 May 25;56(6). pii: e00225-18. doi: 10.1128/JCM.00225-18. Print 2018 Jun.

6.

An Evaluation of the Prevalence of Vancomycin-Resistant Enterococci (VRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospital Food.

Kwon JH, Reske KA, Hink T, Seiler SM, Wallace MA, Bommarito KM, Burnham CD, Dubberke ER.

Infect Control Hosp Epidemiol. 2017 Nov;38(11):1373-1375. doi: 10.1017/ice.2017.207. Epub 2017 Sep 27. No abstract available.

7.

Assessment of Healthcare Worker Protocol Deviations and Self-Contamination During Personal Protective Equipment Donning and Doffing.

Kwon JH, Burnham CD, Reske KA, Liang SY, Hink T, Wallace MA, Shupe A, Seiler S, Cass C, Fraser VJ, Dubberke ER.

Infect Control Hosp Epidemiol. 2017 Sep;38(9):1077-1083. doi: 10.1017/ice.2017.121. Epub 2017 Jun 13.

8.

Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.

Kwon JH, Reske KA, Hink T, Burnham CA, Dubberke ER.

J Clin Microbiol. 2017 Feb;55(2):596-605. doi: 10.1128/JCM.02126-16. Epub 2016 Dec 7.

9.

An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients.

Kwon JH, Lanzas C, Reske KA, Hink T, Seiler SM, Bommarito KM, Burnham CD, Dubberke ER.

Infect Control Hosp Epidemiol. 2016 Dec;37(12):1401-1407. Epub 2016 Oct 3. Erratum in: Infect Control Hosp Epidemiol. 2017 Feb;38(2):258.

10.

Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients.

Kwon JH, Bommarito KM, Reske KA, Seiler SM, Hink T, Babcock HM, Kollef MH, Fraser VJ, Burnham CA, Dubberke ER; Centers for Disease Control and Prevention (CDC) Prevention Epicenters.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1451-4. doi: 10.1017/ice.2015.195. Epub 2015 Aug 27.

11.

Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.

Gonzalez MD, Wallace MA, Hink T, Dubberke ER, Burnham CA.

Antimicrob Agents Chemother. 2015 Nov;59(11):7084-5. doi: 10.1128/AAC.01670-15. Epub 2015 Aug 17.

12.

Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.

Dubberke ER, Reske KA, Seiler S, Hink T, Kwon JH, Burnham CA.

Antimicrob Agents Chemother. 2015 Aug;59(8):4533-43. doi: 10.1128/AAC.00642-15. Epub 2015 May 18.

13.
14.

Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.

Zhou Y, Burnham CA, Hink T, Chen L, Shaikh N, Wollam A, Sodergren E, Weinstock GM, Tarr PI, Dubberke ER.

J Clin Microbiol. 2014 Dec;52(12):4260-6. doi: 10.1128/JCM.02115-14. Epub 2014 Oct 1.

15.

Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Alasmari F, Seiler SM, Hink T, Burnham CA, Dubberke ER.

Clin Infect Dis. 2014 Jul 15;59(2):216-22. doi: 10.1093/cid/ciu258. Epub 2014 Apr 21.

16.

A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.

Hink T, Burnham CA, Dubberke ER.

Anaerobe. 2013 Feb;19:39-43. doi: 10.1016/j.anaerobe.2012.12.001. Epub 2012 Dec 13.

17.

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections.

Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM Jr.

J Clin Microbiol. 2011 Aug;49(8):2887-93. doi: 10.1128/JCM.00891-11. Epub 2011 Jun 22.

Supplemental Content

Support Center